Physician profile

Michael S Broukhim

Interventional Cardiology · Santa Monica, CA

NPI 1609064880

$16,706.59

in general payments reported to CMS, 2019-2025

51 companies · $4,515 in 2025

The $4,515 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,511.00
Travel and Lodging$756.86

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amgen INC. $2,008.85 2019-2025 Repatha, Repatha
Recor Medical INC $1,472.80 2024-2025 Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System
Lantheus Medical Imaging, INC. $1,368.00 2020
E.R. Squibb & Sons, L.L.C. $1,091.88 2019-2025 Camzyos, Eliquis
Novartis Pharmaceuticals Corporation $1,038.63 2019-2025
Abiomed $929.75 2019-2025 Impella
Shockwave Medical, INC $908.38 2022-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Edwards Lifesciences Corporation $864.02 2019-2025 Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve
Philips North America LLC $793.22 2019-2024 (6366) Sync, (Bq9) Coronary Ivus
Boston Scientific Corporation $709.93 2020-2025 Avvigo Guidance System, General - Balloon Catheters, Emerge Push
Janssen Pharmaceuticals, INC $612.70 2019-2024 Xarelto
Abbott Laboratories $569.12 2019-2025 Navitor, Diamondback Coronary, Xience Skypoint
Medtronic, INC. $443.63 2022-2025 Corevalve Evolut R, Symplicity G3, Onyx Frontier
Boehringer Ingelheim Pharmaceuticals, INC. $372.14 2019-2025 Jardiance
Astrazeneca Pharmaceuticals LP $296.04 2019-2024 Farxiga
Show all 51 companies
CompanyGeneral paymentsYearsTop products
Esperion Therapeutics, INC. $257.61 2023-2025 Nexletol, Nexlizet
Lexicon Pharmaceuticals, INC. $254.83 2023-2024 Inpefa
Biotronik INC. $248.67 2019-2021
Inari Medical, INC. $191.92 2022
Novo Nordisk INC $180.51 2021-2025 Ozempic, Rybelsus, Wegovy
Kiniksa Pharmaceuticals, LTD. $176.46 2022-2023 Arcalyst
Biosense Webster, INC. $152.34 2023 Carto 3
Cardiva Medical, INC. $151.20 2024 Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs
Pfizer INC. $145.04 2021-2025
Bayer Healthcare Pharmaceuticals INC. $132.50 2023
Scpharmaceuticals INC. $117.57 2023
Amarin Pharma, INC. $116.76 2019-2022
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $108.72 2022-2024 Lifevest
Alnylam Pharmaceuticals INC. $102.43 2021-2023 Amvuttra
Akcea Therapeutics, INC. $100.75 2019-2020
Itamar Medical INC $96.36 2021-2024 Watchpatone
Stryker Corporation $93.73 2025 Clottriever Bold Catheter, Artix Mt, Inthrill Thrombectomy Catheter
Penumbra, INC. $56.94 2024 Indigo System
Heartflow, INC. $55.97 2022-2023 Ffrct
Kiniksa Pharmaceuticals International, Plc $53.98 2024 Arcalyst
Cardiovascular Systems INC. $53.77 2021-2022
Irhythm Technologies, INC. $52.22 2023-2024 Zio Xt Patch, Zio Monitor
Otsuka America Pharmaceutical, INC. $41.90 2019
Merck Sharp & Dohme LLC $39.21 2021-2023 Verquvo
Inspire Medical Systems, INC. $32.50 2025 Inspire
Kowa Pharmaceuticals America, INC. $30.48 2019
Lundbeck LLC $24.29 2019
Teleflex LLC $22.56 2023 Guideliner
Kestra Medical Technology Services, INC. $21.47 2025 Assure Wcd
Csl Behring $21.25 2020
Actelion Pharmaceuticals US, INC. $20.34 2024 Uptravi, Opsumit
Sanofi-Aventis U.S. LLC $18.74 2019
Baxter Healthcare $15.52 2025 Hillrom - Cardiac Ambulatory Monitor
Tactile Systems Technology INC $13.56 2020
Medtronic Vascular, INC. $13.42 2019
Chiesi USA, INC. $11.98 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael S Broukhim

$16,706.59

in general payments reported 2019-2025

Years
2019-2025
Top company
Amgen INC.
Context
The $4,515 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/163080/michael-s-broukhim

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.